Nitazene Control Act

HR 5032, the Nitazene Control Act, permanently classifies all nitazenes and their chemical analogs as Schedule I controlled substances under the Controlled Substances Act. This means these synthetic opioids, which are significantly more potent than fentanyl and linked to overdose deaths, are now federally banned for all non-medical use. The bill creates a broad chemical definition covering substances with specific structural features (a benzimidazole core and mu-opioid receptor activity), preventing new analogs from evading regulation. It includes a temporary 18-month exemption for researchers already studying these substances under active FDA-approved protocols, requiring them to notify the DEA and apply for proper registration within that period. The law directly affects the illicit drug market and ongoing research involving nitazenes, aiming to streamline enforcement and prevent new analogs from entering the supply chain.